SEARCH

SEARCH BY CITATION

References

  • Abdool Karim SS, Naidoo K & Grobler A et al. (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. New England Journal of Medicine 362, 697706.
  • Abdool Karim SS, Naidoo K & Grobler A et al. (2011) Integration of antiretroviral therapy with tuberculosis treatment. New England Journal of Medicine 365, 14921501.
  • Blanc FX, Sok T & Laureillard D et al. (2011) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. New England Journal of Medicine 365, 14711481.
  • Cohen K & Meintjes G (2010) Management of individuals requiring antiretroviral therapy and TB treatment. Current Opinion in HIV and AIDS 5, 6169.
  • Colebunders R, John L, Huyst V, Kambugu A, Scano F & Lynen L (2006) Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. The International Journal of Tuberculosis and Lung Disease 10, 946953.
  • Division of Leprosy, Tuberculosis and Lung Disease (2006) Guidelines for Implementing TB-HIV Collaborative Activities in Kenya: What Health Care Workers' Need to Know. Ministry of Public Health and Sanitation, Nairobi.
  • Division of Leprosy, Tuberculosis and Lung Disease (2009) Guidelines on Management of Leprosy and Tuberculosis. Kenyan Ministry of Public Health and Sanitation, Nairobi. http://www.nltp.co.ke/docs/DLTLD_Treatment_Guidelines.pdf (retrieved July 18, 2012)
  • Githui W, Nunn P & Juma E et al. (1992) Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle and Lung Disease 73, 203209.
  • Havlir DV, Kendall MA & Ive P et al. (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. New England Journal of Medicine 365, 14821491.
  • Huerga H, Spillane H, Guerrero W, Odongo A & Varaine F (2010) Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. The International Journal of Tuberculosis and Lung Disease 14, 611615.
  • Kyeyune R, den Boon S & Cattamanchi A et al. (2010) Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. Journal of Acquired Immune Deficiency Syndromes (1999) 55, 446450.
  • Lawn SD & Churchyard G (2009) Epidemiology of HIV-associated tuberculosis. Current Opinion in HIV and AIDS 4, 325333.
  • Leone S, Nicastri E, Giglio S, Narciso P, Ippolito G & Acone N (2010) Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. International Journal of Infectious Diseases 14, e283e291.
  • Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A & Sungkanuparph S (2006) Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999), 43, 4246.
  • Pope DS, Deluca AN & Kali P et al. (2008) A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 48, 190195.
  • Scott JA, Hall AJ & Muyodi C et al. (2000) Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 355, 12251230.
  • Török ME & Farrar JJ (2011) When to start antiretroviral therapy in HIV-associated tuberculosis. New England Journal of Medicine 365, 15381540.
  • Török ME, Yen NT & Chau TT et al. (2011) Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis. Clinical Infectious Diseases 52, 13741383.
  • Velasco M, Castilla V & Sanz J et al. (2009) Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. Journal of Acquired Immune Deficiency Syndromes (1999) 50, 148152.
  • WHO (2010a). Global Tuberculosis Control: WHO 2010 Report. WHO Press, Geneva, Switzerland.
  • WHO (2010b) The Global Plan to Stop TB 2011–2015. Transforming the Fight: Towards Elimination of Tuberculosis. WHO Press, Geneva, Switzerland.
  • Yotebieng M, Van Rie A & Moultrie H et al. (2010) Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England) 24, 13411349.